EnBiotix, Inc. Closes $11M Pre-Merger Financing

BOSTON, Dec. 29 (Korea Bizwire) – EnBiotix, Inc., a rare disease company currently focused on chronic respiratory disorders, today announced the closing of an $11M pre-merger, convertible note round of financing (“the Financing”) comprised of Vectura Group plc, the Cystic Fibrosis Foundation and Sanford Biosciences LLC. The Financing was led by Vectura Group plc (“Vectura”), a [...]